UK markets open in 3 hours 57 minutes

Mithra Pharmaceuticals SA (0R91.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
6.41-0.09 (-1.31%)
At close: 06:18PM BST
Full screen
Previous close6.49
BidN/A x N/A
AskN/A x N/A
Day's range6.30 - 6.57
52-week range1.29 - 6.80
Avg. volume10,298
Market capN/A
Beta (5Y monthly)0.45
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Mithra secures court protection measures to advance monetization process

    Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing Organization.Approval of Judicial Reorganization Proceedings for Novalon SA, facilitating an amicable agreement with some creditors and restructuring the debt of Mithra's complex therapeutics business.Mithra Advances Monetization Process with Court Protection Measures, marking significant milestones in the company's c

  • GlobeNewswire

    Mithra reports full year 2023 financial results

    Mithra reports full year 2023 financial results Revenues were EUR 40.2 million, down from the 2022 result of EUR 67.0 million which was positively impacted by exceptional upfront cash payments from partnerships.Product sales were EUR 18.7 million, up +19.3% vs EUR 15.7 million in 2022.ESTELLE® product sales reached EUR 10.4 million in 2023 beating the September 2023 guidance of EUR 8.5 million and up from EUR 9.2 million in 2022.Cash position, at EUR 9.0 million at end of 2023, is down compared

  • Globe Newswire

    Mithra announces changes to its executive management

    Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces the termination of the management agreement with David Horn Solomon1 as CEO and his replacement by Christophe Maréchal2 and Xavier Paoli as co-CEOs. As announced today, Mithra will commence a monetization process involving the sale of various selected assets of Mithra and/or the business as a whole (the "Monetiz